{"entity":{"type":"insider","cik":"0001756253","url":"/insider/0001756253","json_url":"/insider/0001756253.json","name":"Smith Mark Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2020-08-12","last":"2026-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Smith Mark Douglas","source":"filing","n_filings":12,"first_seen":"2020-08-12","last_seen":"2026-06-17"}],"transactions":[{"id":5988648,"accession":"0001756253-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001756253-26-000004","line_url":"/filing/0001756253-26-000004#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1157.0,"shares_display":"1,157","price_per_share":230.55,"price_display":"230.55","price_state":"stated","total_value":266746.35,"total_display":"266,746.35","total_whole":"266,746","shares_owned_after":9680.0,"shares_owned_after_display":"9,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":4143864,"accession":"0001127602-25-018936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-018936","line_url":"/filing/0001127602-25-018936#line-2","is_derivative":false,"issuer_cik":"0001412408","issuer_name":"Phreesia, Inc.","issuer_ticker":"PHR","issuer_name_source":null,"issuer_url":"/issuer/0001412408","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":203000.0,"total_display":"203,000.00","total_whole":"203,000","shares_owned_after":37353.0,"shares_owned_after_display":"37,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-07-03","scope":"insider"},{"id":3269088,"accession":"0001628280-24-037693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-037693","line_url":"/filing/0001628280-24-037693#line-1","is_derivative":false,"issuer_cik":"0001477449","issuer_name":"Teladoc Health, Inc.","issuer_ticker":"TDOC","issuer_name_source":null,"issuer_url":"/issuer/0001477449","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":7.078,"price_display":"7.08","price_state":"stated","total_value":28312.0,"total_display":"28,312.00","total_whole":"28,312","shares_owned_after":8355.0,"shares_owned_after_display":"8,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-15","filed_date":"2024-08-19","scope":"insider"},{"id":2840636,"accession":"0001127602-24-020800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-020800","line_url":"/filing/0001127602-24-020800#line-2","is_derivative":false,"issuer_cik":"0001412408","issuer_name":"Phreesia, Inc.","issuer_ticker":"PHR","issuer_name_source":null,"issuer_url":"/issuer/0001412408","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":175000.0,"total_display":"175,000.00","total_whole":"175,000","shares_owned_after":30653.0,"shares_owned_after_display":"30,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-22","scope":"insider"},{"id":8738548,"accession":"0001765581-23-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-23-000110","line_url":"/filing/0001765581-23-000110#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":119.27,"price_display":"119.27","price_state":"stated","total_value":49735.59,"total_display":"49,735.59","total_whole":"49,736","shares_owned_after":6888.0,"shares_owned_after_display":"6,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":7823488,"accession":"0001765581-23-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-23-000090","line_url":"/filing/0001765581-23-000090#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":138.1579,"price_display":"138.16","price_state":"stated","total_value":171453.9539,"total_display":"171,453.95","total_whole":"171,454","shares_owned_after":7305.0,"shares_owned_after_display":"7,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-15","scope":"insider"},{"id":8634046,"accession":"0001562180-23-003442","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-003442","line_url":"/filing/0001562180-23-003442","is_derivative":false,"issuer_cik":"0001412408","issuer_name":"Phreesia, Inc.","issuer_ticker":"PHR","issuer_name_source":null,"issuer_url":"/issuer/0001412408","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":30.76675,"price_display":"30.77","price_state":"stated","total_value":215367.25,"total_display":"215,367.25","total_whole":"215,367","shares_owned_after":16612.0,"shares_owned_after_display":"16,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider","n_lines":2},{"id":6989544,"accession":"0001765581-22-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-22-000130","line_url":"/filing/0001765581-22-000130#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":420.0,"shares_display":"420","price_per_share":154.6806,"price_display":"154.68","price_state":"stated","total_value":64965.852,"total_display":"64,965.85","total_whole":"64,966","shares_owned_after":5471.0,"shares_owned_after_display":"5,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6379112,"accession":"0001765581-22-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-22-000098","line_url":"/filing/0001765581-22-000098#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":152.3225,"price_display":"152.32","price_state":"stated","total_value":165879.2025,"total_display":"165,879.20","total_whole":"165,879","shares_owned_after":5891.0,"shares_owned_after_display":"5,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":5031713,"accession":"0001765581-21-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-21-000133","line_url":"/filing/0001765581-21-000133#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":121.3,"price_display":"121.30","price_state":"stated","total_value":50582.1,"total_display":"50,582.10","total_whole":"50,582","shares_owned_after":4419.0,"shares_owned_after_display":"4,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":4507588,"accession":"0000899243-21-000766","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-000766","line_url":"/filing/0000899243-21-000766","is_derivative":false,"issuer_cik":"0001412408","issuer_name":"Phreesia, Inc.","issuer_ticker":"PHR","issuer_name_source":null,"issuer_url":"/issuer/0001412408","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":52.56847545,"price_display":"52.57","price_state":"stated","total_value":315410.8527,"total_display":"315,410.85","total_whole":"315,411","shares_owned_after":9199.0,"shares_owned_after_display":"9,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":3},{"id":2778996,"accession":"0000899243-20-022171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-022171","line_url":"/filing/0000899243-20-022171#line-2","is_derivative":false,"issuer_cik":"0001412408","issuer_name":"Phreesia, Inc.","issuer_ticker":"PHR","issuer_name_source":null,"issuer_url":"/issuer/0001412408","owner_cik":"0001756253","owner_name":"Smith Mark Douglas","owner_display_name":"Smith Mark Douglas","owner_url":"/insider/0001756253","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":30.3041,"price_display":"30.30","price_state":"stated","total_value":181824.6,"total_display":"181,824.60","total_whole":"181,825","shares_owned_after":6110.0,"shares_owned_after_display":"6,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Director","n_filings":6,"first_seen":"2021-12-06","last_seen":"2026-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001412408","name":"Phreesia, Inc.","url":"/issuer/0001412408","role":"Director","n_filings":5,"first_seen":"2020-08-12","last_seen":"2025-07-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001477449","name":"Teladoc Health, Inc.","url":"/issuer/0001477449","role":"Director","n_filings":1,"first_seen":"2024-08-19","last_seen":"2024-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001756253","retrieved_at":"2026-08-23T00:47:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}